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Abstract
Purpose: The aim of this study was to investigate the pathway to amplification technologies for children who passed their 
universal newborn hearing screening (UNHS) bilaterally with the intent of revealing effective strategies to identify children 
with acquired or progressive hearing losses. Additionally, the degrees, types, and causes of hearing loss, as well as the 
types of amplification used by the patients were investigated.
Methodology: Medical records were reviewed for 102 children who passed their UNHS bilaterally and who are enrolled in 
the Boston Children’s Hospital Amplification or Cochlear Implant Programs. Of the 204 total ears, 177 ears were identified 
with hearing loss and were included in the study.
Conclusion: More than half of new hearing loss identifications in children over 11 years and approximately one third of 
all new hearing loss identifications resulted from a referred hearing screening. For children under age three, a speech-
language delay was the most common reason for referral leading to identification of a permanent, postnatal hearing loss. 
This study emphasizes the importance of routine hearing screenings in school-aged children as well as highlights the 
need for audiological evaluations when signs of childhood hearing loss arise, such as a speech-language delay.
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Universal Newborn Hearing Screening (UNHS) has 
remarkable value in decreasing the average age of hearing 
loss identification (Dalzell et al., 2000; Vohr et al., 1998); 
however, it is possible for a child to pass the newborn 
hearing screening with a mild, congenital hearing loss. 
Current automated auditory brainstem response (AABR) 
testing and otoacoustic emissions (OAEs) screening tools 
frequently use a 30–35 dB criterion level, which would 
fail to capture newborns with a slight to mild hearing loss. 
Johnson et al. (2005) estimates that approximately 23% of 
newborns who have a permanent hearing loss would pass 
a UNHS conducted via AABR as a result of the chosen 
screening level. 
In addition, there are many causes of delayed-onset 
congenital or acquired hearing loss that can occur in 
childhood, including hearing loss associated with genetic 
mutations, infectious diseases, anatomic abnormalities, 
trauma, and ototoxicity (Kenna, 2015). By age nine, 25% 
of permanent childhood hearing loss is postnatal in nature, 
suggesting that while the UNHS is playing a significant role 
in the identification of permanent childhood hearing loss, 
provisions must also be in place to identify children who 
acquire hearing loss postnatally (Weichbold et al., 2006; 
Watkin & Baldwin, 2011). Among the cases of permanent 
childhood hearing loss identified through post-neonatal 
care pathways, hearing loss is most commonly identified 
due to school hearing screenings and parental concerns 
regarding hearing (Dedhia et al., 2013; Watkin & Baldwin, 
2011). Once identified, Walker et al. (2014) observed 
significantly longer delays from hearing loss identification 
to intervention for children with postnatal hearing loss 
compared to children who were identified in the newborn 
period. The same investigation revealed that degree of 
hearing loss predicted age at follow-up clinical services 
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Note. Age of identification was not significantly different between these two groups (t78 = -0.6, p = 0.5).
Table 1
Participant Breakdown by Sex and Number of Ears with 
Hearing Loss (Unilateral vs. Bilateral)
for children with postnatally identified hearing loss, such 
that children with more severe losses received services 
at younger ages compared to children with milder hearing 
loss. 
Approximately 40% of patients in the Amplification 
Program at Boston Children’s Hospital (BCH) passed their 
UNHS bilaterally. In the BCH Cochlear Implant Program, 
18% of patients with known UNHS outcomes passed 
in both ears. We designed this study to investigate the 
pathway to amplification technologies for children who 
passed their UNHS with the aim of revealing the factors 
that led to the later identification of children with hearing 
loss. This study addresses the average age of hearing loss 
identification and the average time between hearing loss 
identification and amplification fittings in this population. 
Additionally, we describe the degree, type, and causes 
of hearing loss observed. Based on previous studies 
described above, we hypothesized that most children 
would be identified through childhood hearing screening 
programs and that more severe hearing losses would have 
a shorter time between identification and intervention. 
Methods
We reviewed medical records of 102 children who passed 
their UNHS and who are enrolled in the BCH Amplification 
and/or Cochlear Implant Programs. Medical records were 
included for review from July 1999 through July 2018. 
Participants were included in this study if they were (a) 
identified with hearing loss between 0–22 years of age, (b) 
had known outcomes of their UNHS, and (c) were users of 
amplification technologies including hearing aids, cochlear 
implants, or bone anchored hearing systems. Of the 204 
ears, 177 ears were identified with permanent hearing 
loss and were included in the study. Table 1 indicates 
the breakdown of participants by sex and by whether the 
hearing loss was unilateral or bilateral at initial diagnosis. 
Male Female Total
Bilateral 37 (36.3%) 38 (37.3%) 75 (73.5%)
Unilateral 16 (15.7%) 11 (10.8%) 27 (26.5%)
Total 53 (52.0%) 49 (48.0%) 102 (100%)
Figure 1
Histogram of Age (in Years) of Identification of Hearing Loss Split by Unilateral Versus Bilateral Hearing Loss
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Figures 1 and 2 respectively display the age of 
identification broken down by laterality of hearing loss and 
by sex. Note that race/ethnicity data are not reliably coded 
in the hospital medical record and are not included.
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When reviewing the medical records, we investigated 
certain criteria to describe the type, degree, and 
configuration of the hearing losses. The types of hearing 
loss were determined to be sensorineural, conductive, 
or mixed. We categorized the patients’ hearing loss 
configurations using the terms flat, rising, sloping, cookie 
bite, reverse cookie bite, notched, or unconventional. 
The patients’ best threshold degrees and worst threshold 
degrees were documented to fully capture their hearing 
loss and to not exclude those with irregular configurations. 
Additionally, the patients’ 2000 Hz pure tone threshold 
degrees were documented due to the importance of 2000 
Hz in speech recognition.
To capture the patients’ timeline to amplification 
technologies, we looked at the month and year of initial 
hearing loss diagnosis and calculated the years between 
birth and hearing loss identification to find the average 
age of identification. We then investigated the month and 
year of initial hearing aid fitting and calculated the years 
between hearing loss identification and hearing aid fitting. 
For patients who use cochlear implants, we documented 
the date of initiation for their pre-surgical hearing aid trial, 
if known; if there was no documented hearing aid trial, the 
date of intervention was marked as the implant surgery 
date. With this information we were able to calculate 
the average amount of time between initial hearing loss 
diagnosis and amplification fitting across all of our patients.  
We were also interested in capturing identifiable reasons 
for the referral for audiological evaluations. These fields 
included a referred hearing screening at the pediatrician 
or school, speech-language delay, pediatrician concern, 
parental concern, suspected or confirmed diagnosis of 
autism spectrum disorder, or other medical referral from 
a specialist. These reasons were not mutually exclusive, 
and, for some patients, more than one reason was 
selected. In our records, it was not always clear whether 
the hearing screening was performed at the doctor’s 
office or the school; hence these are combined. Tier 1 
and 2 risk factors for childhood hearing loss outlined by 
the Massachusetts Department of Public Health (Table 
2) were investigated as possible predictors for late-onset 
childhood hearing loss. The risk factor tier indicates when 
an infant would receive follow-up hearing testing. Infants 
born with Tier 1 risk factors are recommended to receive 
a diagnostic ABR by 3 months of age. This appointment is 
scheduled by the birth hospital prior to discharge. Infants 
born with Tier 2 risk factors are recommended to receive 
a diagnostic hearing assessment at 6–9 months of age 
(Stewart, 2017). This is coordinated by the medical home.
Knowing the etiology of hearing loss was important in 
the determination of whether the participant’s hearing 
loss was acquired, presumably congenital missed by 
the UNHS, or delayed-onset congenital. If the etiology 
of the hearing loss was known, we categorized them as 
Note. Age of identification was not significantly different between these two groups (t98 = -0.08, p = 0.9).
Figure 2
Histogram of Age (in years) of Identification of Hearing Loss Split by Sex of Participant
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genetic, such as connexin-26 or related with a syndrome; 
anatomical, such as enlarged vestibular aqueduct (EVA); 
caused by infection, such as cytomegalovirus (CMV); 
caused by ototoxic medications, such as chemotherapy; 
or due to another cause. We further wanted to investigate 
whether the patients had a coexisting diagnosis related to 
neurologic status, such as Autism Spectrum Disorder or 
intellectual disability.
Results
Approximately half (52.0%) of hearing losses were 
sensorineural in nature. Conductive hearing loss 
comprised 30.5% of hearing losses in our cohort and the 
remaining 17.5% of hearing losses were mixed in nature. 
Figure 3 illustrates degree of hearing loss for the 177 ears 
in the study based on the 2000 Hz threshold, the best 
threshold, and the poorest threshold. For 63.8% of ears, 
the 2000 Hz threshold at hearing loss identification was 
in the normal hearing or mild hearing loss range. 2000 Hz 
thresholds were observed in the moderate or moderately-
severe hearing loss range for 26.0% of ears and in the 
severe to profound range for the remaining 10.1% of ears. 
At initial identification, more than 80% of ears had at least 
one pure-tone threshold in the normal to mild loss range 
and more than 60% of ears had at least one pure-tone 
threshold in the moderate to profound range. The majority 
(90.2%) of participants wore hearing aids; 8.8% used 
cochlear implants exclusively or as a bimodal solution. The 
rest of the participants (1%) used a bone-anchored device.
Etiologies of hearing loss varied greatly across 
participants. Unknown etiology accounted for 37.3% 
of participants, often despite the use of temporal bone 
imaging and genetic testing under management by an 
otolaryngologist. Acquired conditions accounted for 
Table 2
Massachusetts Department of Public Health Tier 1 and Tier 2 Risk Factors for Hearing Loss
Tier 1 Tier 2
• Maternal CMV
• Down Syndrome
• Cleft lip/palate
• Bacterial meningitis
• Craniofacial anomalies
• Syndromes associated with hearing loss
• Perinatal asphyxia
• ECMO
• Hyperbilirubinemia (> 20 mg/dL bilirubin)
• Permanent hearing loss in immediate 
family
• Parental or medical provider concern
• > 10 days mechanical ventilation
• ≤ 32 weeks gestational age
• < 1500 grams birth weight
• Permanent hearing loss in extended family
• Herpes, rubella, syphilis, or toxoplasmosis
• Head trauma
• Ear pits with preauricular tags
• Ototoxic medications (> 7 day course in 
conjunction with loop diuretics)
• NICU stay > 5 days
Note. CMV = cytomegalovirus, ECMO = Extracorporeal membrane oxygenation, NICU = Newborn Intensive Care Unit.
31.4% of hearing loss, including conditions such as 
chronic otitis media (53.1%), cholesteatoma (25.0%), or 
ototoxicity (18.8%). Syndrome related losses accounted 
for 16.7% of participants, of which the most common was 
Down syndrome (58.8%). Enlarged vestibular aqueducts 
accounted for 10.8% of participants. Connexin-26 genetic 
mutations accounted for 3.9% of participants. Congenital 
CMV (cCMV) accounted for 2.9% of participants. 
Incidentally, 5.9% of participants had a comorbid diagnosis 
of Autism Spectrum Disorder and 4.9% of participants had 
a comorbid diagnosis of intellectual disability.
Table 2 summarizes hearing loss identification and 
amplification fitting timelines by type of hearing loss. The 
average age of hearing loss identification was 5.7 years 
(SD = 3.6 years). Group means for type of hearing loss 
were evaluated for differences using one-way Analysis 
of Variance (ANOVA) testing. No significant difference 
for age of hearing loss identification was observed 
based on hearing loss type, F(2, 174) = 2.79, p = 0.06. 
Once identified with hearing loss, the average time from 
diagnosis to amplification fitting was 2.0 years (SD = 2.8 
years). A significant main effect of type of hearing loss 
was observed for the time from hearing loss diagnosis to 
amplification fitting, F(2, 174) = 6.45, p < 0.01. A Tukey 
test for multiple comparison of means, using a 99% 
confidence level, revealed that children with sensorineural 
hearing loss had a significantly shorter time from hearing 
loss diagnosis to amplification fitting than children with 
conductive hearing loss (p < 0.01). No difference was 
observed when comparing children with mixed hearing 
loss to those with either sensorineural (p = 0.15) or 
conductive hearing losses (p = 0.63). 
Tier 1 and 2 risk factors for hearing loss were investigated 
as possible predictors for late-onset childhood hearing 
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loss. At least one Tier 1 or 2 risk factor for hearing loss in 
the neonatal period was present for 40.2% of our cohort. 
The average age of hearing loss identification for those 
with at least one risk factor was 5.6 years (SD = 4.2 years) 
compared to 5.8 years (SD = 2.8 years) for those without a 
risk factor. A Tier 1 risk factor for hearing loss was present 
in 24.5% of participants. The most frequent Tier 1 risk 
factor was an immediate family history of hearing loss 
(n = 9) followed by cCMV (n = 3). 19.6% of participants 
had a Tier 2 risk factor for hearing loss. Among Tier 2 risk 
factors, the most commonly observed was a neonatal 
intensive care unit stay of greater than 5 days (n = 11). Six 
participants had an extended family history of hearing loss. 
Five participants were given ototoxic medication in the 
neonatal period. Five participants had a gestational age of 
less than 32 weeks. 
Table 3 shows reasons for audiological referral by age 
group. Approximately 1 in 4 patients did not have an 
identifiable reason for audiological evaluation. For children 
older than 3, a hearing screening was the primary reason 
for referral for diagnostic hearing testing. For children 
under age three, a speech-language delay was the most 
common reason for referral leading to identification of 
a permanent, postnatal hearing loss. A referral from a 
specialist (e.g., geneticist, developmental pediatrician, 
cardiologist) led to diagnosis for 22.1% of patients. 
Table 3
Reason for Referral for Audiological Evaluation by Age Group (Age of Diagnosis)
Infant/Toddler 
(0-3 Years)
Preschool      
(4-5 Years)
Early School    
(6-10 Years)
Later School 
(11+ Years)
All Ages
n 25 31 39 7 102
Referred 
Screening
0.0% 38.1% 35.5% 57.1% 27.5%
Speech-
Language Delay
37.9% 22.9% 16.1% 14.3% 25.5%
Referral from 
Specialist
27.6% 17.1% 22.6% 0.0% 20.6%
Parent Concern 17.2% 22.9% 9.7% 14.3% 16.7%
Primary Care 
Provider Referral
0.0% 5.7% 6.5% 14.3% 4.9%
No Known 
Reason
34.5% 14.3% 25.8% 14.3% 23.5%
ANOVA was performed to determine whether severity 
of hearing loss was related to identification of hearing 
loss. The analysis indicated no significant relationship 
between severity of hearing loss, either based on best 
hearing threshold or best threshold at 2 kHz, and number 
of months between identification of hearing loss and 
first fitting with amplification. The average time between 
identification and fitting was 25.5 months (SD = 34.9 
months).
Discussion
The implementation of the UNHS has made a significant 
impact on early hearing detection and intervention. 
However, UNHS cannot stand alone in detection of 
childhood hearing loss. As observed by Walker et al. 
(2014), this study indicates that children identified with 
hearing loss through post-natal pathways experience 
long delays between hearing loss identification and the 
implementation of hearing loss interventions. 
Documented risk factors for hearing loss fall into two tiers, 
which then determines the timeline for initial diagnostic 
testing. Children with a Tier 1 or Tier 2 risk factor requiring 
diagnostic testing may have not developed hearing loss 
by the time of initial appointment despite the possibility of 
later-onset hearing loss. This supports routine monitoring 
and screening of hearing to document any changes in a 
prompt manner. However, the risk factors do not capture 
every child who may develop a delayed-onset congenital 
or acquired hearing loss. The list of risk factors increases 
the number of children being diagnostically monitored for 
potential hearing loss in childhood but cannot encompass 
or predict all children that will require audiological 
evaluations.  This is supported by our cohort as children 
with and without risk factors were included.
Children who pass their UNHS, but experience signs 
of hearing loss during childhood must be appropriately 
referred to an audiologist trained to evaluate hearing 
in pediatric patients. The most frequent catalyst for 
hearing loss identification in our cohort was referring on a 
routine hearing screening, consistent with published data 
(Dedhia et al., 2013; Watkin & Baldwin, 2011). Our data 
demonstrate the importance and necessity of school- and 
primary care provider-based hearing screenings in the 
process of identifying and treating children with hearing 
loss. There may have been delays that we could not 
capture in this study. For instance, if a patient referred their 
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school screening and then went to their physician for a 
repeat screening and then was referred to our clinic, this 
may have caused added delay to the time of diagnosis. 
Additionally, our data show the importance of referring 
children with speech delays for hearing evaluations, even 
if they passed the newborn hearing screening. This was 
the primary route to identification for children under 3 
years of age. Speech-language pathologists and Early 
Intervention staff should not assume hearing is normal if a 
child passed their newborn hearing screening and should 
include a hearing test as part of the work-up when a child 
is exhibiting speech and language delays.
We found that the average duration between diagnosis 
and fitting is greater than one year. This suggests there 
is a lesser sense of urgency for these older children than 
there is for children who refer newborn hearing screening 
and are fit with amplification by 6 months. Boston 
Children’s Hospital does abide by the EHDI 1-3-6 guideline 
for newborns, it being tied to a state mandate. These 
data suggest that Boston Children’s may benefit from an 
initiative to fit later-diagnosed children with hearing aids 
within 3 months of diagnosis.
Our data also demonstrate a relative greater average time 
from diagnosis to fitting of children with conductive hearing 
losses. This is not surprising given the time it takes to 
evaluate candidacy for the greater number of medical and 
surgical treatments available for conductive hearing loss. 
Future research may evaluate whether efforts to quickly 
determine the etiology of conductive hearing loss may 
lead to earlier fitting of amplification. Future research may 
evaluate whether there are benefits to fitting amplification 
synchronously with the medical evaluation process instead 
of waiting for the physicians to complete their assessments 
prior to fitting amplification. This finding raises the question 
as to whether the addition of new options for medically 
treating sensorineural hearing loss (e.g., gene therapy) 
may increase time between diagnosis and fitting in the 
coming years.
Conclusions
It is critical to reinforce the importance of regular childhood 
hearing screenings through later school-age years. These 
efforts provide opportunities for earlier identification of 
childhood hearing loss allowing for earlier intervention 
options. Family members, educational professionals and 
clinicians alike should be aware of and pay attention to 
signs of childhood hearing loss, such as speech-language 
delay, academic difficulties, and increased exhaustion at 
the end of a school day to ensure proper referrals lead to 
early diagnosis. Pediatric medical centers should ensure 
that, once diagnosed with hearing loss, older children are 
being fit with amplification with as little delay as possible, 
similar to the 1-3-6 guidelines for newborns.
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